{"id":"prozac","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[{"effect":"Nausea","drugRate":"","severity":"common","organSystem":""},{"effect":"Insomnia","drugRate":"","severity":"common","organSystem":""},{"effect":"Headache","drugRate":"","severity":"common","organSystem":""},{"effect":"Anxiety","drugRate":"","severity":"common","organSystem":""},{"effect":"Nervousness","drugRate":"","severity":"common","organSystem":""},{"effect":"Tremor","drugRate":"","severity":"common","organSystem":""},{"effect":"Diarrhea","drugRate":"","severity":"common","organSystem":""},{"effect":"Dry mouth","drugRate":"","severity":"common","organSystem":""},{"effect":"Sweating","drugRate":"","severity":"common","organSystem":""},{"effect":"Somnolence","drugRate":"","severity":"common","organSystem":""},{"effect":"Asthenia","drugRate":"","severity":"common","organSystem":""},{"effect":"Libido decreased","drugRate":"","severity":"common","organSystem":""},{"effect":"Abnormal ejaculation","drugRate":"","severity":"common","organSystem":""},{"effect":"Impotence","drugRate":"","severity":"common","organSystem":""},{"effect":"Dyspepsia","drugRate":"","severity":"common","organSystem":""},{"effect":"Anorexia","drugRate":"","severity":"common","organSystem":""},{"effect":"Rash","drugRate":"","severity":"common","organSystem":""},{"effect":"Abnormal dreams","drugRate":"","severity":"common","organSystem":""},{"effect":"Yawn","drugRate":"","severity":"common","organSystem":""},{"effect":"Vasodilatation","drugRate":"","severity":"common","organSystem":""}],"contraindications":["Abnormal sexual function","Agranulocytosis","Angle-closure glaucoma","Anorexia nervosa","At risk for aspiration","Benign prostatic hyperplasia","Bipolar disorder","Blood coagulation disorder","Bradycardia","Carcinoma of female breast","Cerebrovascular accident","Cerebrovascular disease","Cirrhosis of liver","Conduction disorder of the heart","Dehydration","Diabetes mellitus","Disease of liver","Epilepsy","Esophageal dysmotility","Heart failure","Hepatic failure","Hypercholesterolemia","Hyperglycemia","Hyperlipidemia","Hyperprolactinemia","Hypertriglyceridemia","Hypomania","Hyponatremia","Hypovolemia","Leukopenia","Liver function tests abnormal","Low blood pressure","Lowered convulsive threshold","Mania","Metabolic syndrome X","Myocardial infarction","Myocardial ischemia","Neuroleptic malignant syndrome","Neutropenic disorder","Obesity","Orthostatic hypotension","Paralytic ileus","Seizure disorder","Senile dementia","Serotonin syndrome","Sinus tachycardia","Smokes tobacco daily","Suicidal thoughts","Syndrome of inappropriate vasopressin secretion","Tardive dyskinesia","Transient ischemic attack","Upper gastrointestinal hemorrhage","Weight gain finding"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"trials":[],"_chembl":{"chemblId":"CHEMBL41","moleculeType":"Small molecule","molecularWeight":"309.33"},"aliases":["Prozac as anti-depression treatment"],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Prozac","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T02:39:15.441107+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T02:39:21.774172+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Prozac","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T02:39:22.267535+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL41/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T02:39:23.071467+00:00"}},"offLabel":[],"timeline":[],"_dailymed":{"setId":"c88f33ed-6dfb-4c5e-bc01-d8e36dd97299","title":"PROZAC (FLUOXETINE HYDROCHLORIDE) CAPSULE [DISTA PRODUCTS COMPANY]"},"ecosystem":[],"mechanism":{"target":"Equilibrative nucleoside transporter 4, 5-hydroxytryptamine receptor 6, 5-hydroxytryptamine receptor 2A"},"_scrapedAt":"2026-03-28T05:23:30.538Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T02:39:24.653845+00:00","fieldsConflicting":0,"overallConfidence":0.95},"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Bipolar affective disorder, current episode depression","diseaseId":"bipolar-affective-disorder-current-episode-depression","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Bulimia nervosa","diseaseId":"bulimia-nervosa","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Depressive disorder","diseaseId":"depressive-disorder","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Major depressive disorder","diseaseId":"major-depressive-disorder","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Obsessive-compulsive disorder","diseaseId":"obsessive-compulsive-disorder","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Panic disorder","diseaseId":"panic-disorder","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Premenstrual dysphoric disorder","diseaseId":"premenstrual-dysphoric-disorder","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT00768820","phase":"PHASE4","title":"The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome","status":"RECRUITING","sponsor":"The Chaim Sheba Medical Center","startDate":"2001-05","conditions":"Velocardiofacial Syndrome, Williams Syndrome, Fragile X Syndrome","enrollment":400},{"nctId":"NCT07456501","phase":"NA","title":"Fluoxetine and Understanding Social Experiences","status":"NOT_YET_RECRUITING","sponsor":"University of Oxford","startDate":"2026-03","conditions":"Depression in Adolescence, Antidepressant Activity in Healthy Volunteers, Healthy Adult Participants","enrollment":80},{"nctId":"NCT05575128","phase":"NA","title":"Behavioral Activation and Medication Optimization In Older Adults Undergoing Cardiac Procedures","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2022-11-05","conditions":"Cardiac Surgery, Older Adults, Depression","enrollment":102},{"nctId":"NCT01246765","phase":"","title":"National Pregnancy Registry for Psychiatric Medications","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2008-11","conditions":"Pregnant Women, Psychotropic Drugs","enrollment":5000},{"nctId":"NCT01672255","phase":"EARLY_PHASE1","title":"Hypoglycemia Associated Autonomic Failure in Type 1 Diabetes Mellitus (DM)","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2012-10","conditions":"Type 1 Diabetes, Hypoglycemia Associated Autonomic Failure","enrollment":64},{"nctId":"NCT03228732","phase":"EARLY_PHASE1","title":"The Effects of Fluoxetine and/or DHEA","status":"RECRUITING","sponsor":"University of Maryland, Baltimore","startDate":"2017-12-19","conditions":"Type 1 Diabetes Mellitus","enrollment":60},{"nctId":"NCT05142345","phase":"NA","title":"Care Transition Intervention for Hospitalized Patients With Advanced Cancer","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2021-12-15","conditions":"Cancer, Follow-Up Care, Consultation, Remote","enrollment":286},{"nctId":"NCT00285935","phase":"NA","title":"Cellular Aging and Neurobiology of Depression Study","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2010-12-16","conditions":"Major Depressive Disorder","enrollment":228},{"nctId":"NCT05634707","phase":"EARLY_PHASE1","title":"Evaluation of Fluoxetine and Cytotoxic Lysosomal Stress in Glioma (FLIRT)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Duke University","startDate":"2023-08-05","conditions":"Primary Brain Tumor, Brain Tumor, Recurrent","enrollment":10},{"nctId":"NCT05948553","phase":"PHASE2","title":"Department of Defense PTSD Adaptive Platform Trial - Intervention A - Fluoxetine","status":"RECRUITING","sponsor":"Global Coalition for Adaptive Research","startDate":"2023-11-02","conditions":"Post Traumatic Stress Disorder","enrollment":200},{"nctId":"NCT05422612","phase":"PHASE2","title":"Department of Defense PTSD Adaptive Platform Trial - Master Protocol","status":"RECRUITING","sponsor":"Global Coalition for Adaptive Research","startDate":"2023-11-02","conditions":"Post Traumatic Stress Disorder","enrollment":800},{"nctId":"NCT04899687","phase":"PHASE2","title":"Study of Dextromethorphan in OCD and Related Disorders","status":"RECRUITING","sponsor":"Stanford University","startDate":"2022-01-20","conditions":"Obsessive-Compulsive Disorder, Illness Anxiety Disorder, Body Dysmorphic Disorders","enrollment":60},{"nctId":"NCT04131829","phase":"PHASE1, PHASE2","title":"Brain Network Changes Accompanying and Predicting Responses to Pharmacotherapy in OCD","status":"RECRUITING","sponsor":"Yale University","startDate":"2019-10-14","conditions":"Obsessive-Compulsive Disorder","enrollment":100},{"nctId":"NCT07110831","phase":"PHASE4","title":"Disposition Kinetics of Dolutegravir Among People Living With HIV With Major Depression in Nigeria","status":"NOT_YET_RECRUITING","sponsor":"University of Ibadan","startDate":"2025-08-14","conditions":"Depression, HIV","enrollment":168},{"nctId":"NCT03826875","phase":"PHASE2","title":"Poststroke Depression in Hemorrhagic Stroke","status":"COMPLETED","sponsor":"University of Washington","startDate":"2019-03-01","conditions":"Stroke Hemorrhagic, Depression","enrollment":8},{"nctId":"NCT05976347","phase":"PHASE4","title":"Identifying and Treating Depression in the Orthopaedic Trauma Population","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2025-06-25","conditions":"Depression","enrollment":100},{"nctId":"NCT07048938","phase":"NA","title":"Clinical Effect and Mechanism Study of Five Elements Music Therapy(FEMT) on Depression Disorder","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Mental Health Center","startDate":"2025-07-01","conditions":"Depression Disorder, Depression Disorders, Depressive Disorder","enrollment":120},{"nctId":"NCT05697835","phase":"NA","title":"Perioperative Mental Health in Orthopedic Surgery","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2023-02-27","conditions":"Orthopedic Surgery, Older Adults, Depression","enrollment":104},{"nctId":"NCT05685511","phase":"NA","title":"Behavioral Activation and Medication Optimization For Improving Perioperative Mental Health In Older Adults Undergoing Oncologic Surgery","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2023-03-10","conditions":"Older Adults, Anxiety, Depression","enrollment":105},{"nctId":"NCT03476525","phase":"","title":"Bariatric Surgery and Pharmacokinetics of Fluoxetine","status":"RECRUITING","sponsor":"Norwegian University of Science and Technology","startDate":"2016-11-02","conditions":"Obesity, Morbid","enrollment":12},{"nctId":"NCT00592852","phase":"PHASE4","title":"Fluoxetine for Obsessive-Compulsive Disorder in Children and Adolescents With Bipolar Disorder","status":"TERMINATED","sponsor":"Massachusetts General Hospital","startDate":"2005-12","conditions":"Pediatric Bipolar Disorder, Pediatric OCD","enrollment":13},{"nctId":"NCT02473250","phase":"PHASE4","title":"Prediction of Clinical Response to SSRI Treatment in Bipolar Disorder Using Serotonin 1A Receptor PET Imaging","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2015-01","conditions":"Bipolar Disorder","enrollment":40},{"nctId":"NCT03390933","phase":"PHASE4","title":"Identifying and Treating Depression in Hemodialysis Patients","status":"COMPLETED","sponsor":"MetroHealth Medical Center","startDate":"2018-03-01","conditions":"Depression, Hemodialysis-Induced Symptom","enrollment":16},{"nctId":"NCT00581009","phase":"PHASE1, PHASE2","title":"The Role of Dopamine Metabolism in the Antidepressant Effects of Sleep Deprivation and Sertraline in Depressed Patients","status":"COMPLETED","sponsor":"University of California, Irvine","startDate":"2001-05-30","conditions":"Major Depressive Disorder, Bipolar Disorder","enrollment":49},{"nctId":"NCT03889418","phase":"NA","title":"Opioid Treatment and Recovery Through a Safe Pain Management Program","status":"COMPLETED","sponsor":"Ochsner Health System","startDate":"2019-04-01","conditions":"Depression, Opioid Use, Chronic Pain","enrollment":490},{"nctId":"NCT04377308","phase":"PHASE4","title":"Fluoxetine to Reduce Intubation and Death After COVID19 Infection","status":"COMPLETED","sponsor":"University of Toledo Health Science Campus","startDate":"2020-05-01","conditions":"COVID-19, Cytokine Storm","enrollment":16},{"nctId":"NCT00649636","phase":"PHASE1","title":"Fasting Study of Fluoxetine Capsules 40 mg and Prozac Pulvules 40 mg","status":"COMPLETED","sponsor":"Mylan Pharmaceuticals Inc","startDate":"2006-02","conditions":"Healthy","enrollment":32},{"nctId":"NCT00553917","phase":"","title":"Study to Evaluate the Effectiveness of Certain Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants During Pregnancy and Evaluate Newborn Outcomes","status":"TERMINATED","sponsor":"Indiana University","startDate":"2007-11","conditions":"Depression","enrollment":18},{"nctId":"NCT02893371","phase":"","title":"Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies","status":"TERMINATED","sponsor":"University of New Mexico","startDate":"2016-09","conditions":"Bipolar Disorder","enrollment":1037352},{"nctId":"NCT04436289","phase":"NA","title":"Home Link: Post Hospital Care to Reduce HIV Mortality in South Africa","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2020-07-01","conditions":"HIV/AIDS","enrollment":195},{"nctId":"NCT00533117","phase":"PHASE4","title":"Treating Suicidal Behavior and Self-Mutilation in People With Borderline Personality Disorder","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2001-03","conditions":"Borderline Personality Disorder","enrollment":91},{"nctId":"NCT05110690","phase":"NA","title":"Behavioral Activation and Medication Optimization for Perioperative Mental Health Feasibility Study","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2021-11-17","conditions":"Older Adults, Anxiety, Depression","enrollment":24},{"nctId":"NCT05431413","phase":"PHASE2","title":"Rapid Improvement of Depression of Fluoxetine Combined With ATP","status":"UNKNOWN","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2020-01-07","conditions":"Depression","enrollment":195},{"nctId":"NCT02357849","phase":"PHASE4","title":"Fluoxetine vs Aripiprazole Comparative Trial (FACT)","status":"TERMINATED","sponsor":"Northwell Health","startDate":"2014-07","conditions":"Attenuated Psychosis Syndrome","enrollment":9},{"nctId":"NCT03538691","phase":"PHASE3","title":"A Trial to Evaluate the Efficacy, Safety & Tolerability of Brexpiprazole in the Maintenance Treatment of Adults With Major Depressive Disorder","status":"COMPLETED","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","startDate":"2018-07-13","conditions":"Major Depressive Disorder","enrollment":1149},{"nctId":"NCT03779789","phase":"PHASE4","title":"Vortioxetine in the Elderly vs. Selective Serotonin Reuptake Inhibitors (SSRIs): a Pragmatic Assessment","status":"COMPLETED","sponsor":"Azienda Ospedaliera Universitaria Integrata Verona","startDate":"2019-02-01","conditions":"Major Depressive Disorder","enrollment":362},{"nctId":"NCT05789186","phase":"EARLY_PHASE1","title":"Clinical Study of Cang Ai Volatile Oil (CAVO) on Mild to Moderate Depression in Children and Adolescents","status":"UNKNOWN","sponsor":"Chen Qian","startDate":"2023-05-01","conditions":"Depression","enrollment":108},{"nctId":"NCT05283954","phase":"PHASE2, PHASE3","title":"Use of a Combined Regimen of Fluoxetine, Prednisolone and Ivermectin in the Treatment of Mild COVID-19 to Prevent Disease Progression Progression in Papua New Guinea","status":"WITHDRAWN","sponsor":"Oriol Mitja","startDate":"2022-05-01","conditions":"SARS-CoV2 Infection, COVID-19","enrollment":""},{"nctId":"NCT01545843","phase":"PHASE2","title":"Repeated Partial Sleep Deprivation to Augment SSRI Response in Depression","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2009-03","conditions":"Depression","enrollment":68},{"nctId":"NCT03448159","phase":"PHASE2","title":"Fluoxetine Opens Window to Improve Motor Recovery After Stroke","status":"COMPLETED","sponsor":"University Health Network, Toronto","startDate":"2019-01-01","conditions":"Stroke, Cerebrovascular Accident, Cerebral Infarction","enrollment":52},{"nctId":"NCT02022709","phase":"PHASE4","title":"Efficacy of Exposure and Response Prevention(ERP) and SSRIs in Chinese OCD Patients","status":"COMPLETED","sponsor":"Shanghai Mental Health Center","startDate":"2014-01","conditions":"Obsessive-Compulsive Disorder, Anxiety Disorders, Mental Disorders","enrollment":78},{"nctId":"NCT05532332","phase":"PHASE1","title":"Bioequivalence Study of Fluoxetine in Healthy Adult Subjects Under Fasting Condition","status":"COMPLETED","sponsor":"Future University in Egypt","startDate":"2021-01-18","conditions":"Healthy Subjects","enrollment":34},{"nctId":"NCT03728153","phase":"PHASE2","title":"Measuring Ambulation, Motor, and Behavioral Outcomes With Post-Stroke Fluoxetine in Tanzania","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2019-11-26","conditions":"Acute Stroke, Stroke, Ischemic","enrollment":34},{"nctId":"NCT05378711","phase":"PHASE2","title":"Evaluating the Results of Physician and Parent Decisions to Treat Selective Mutism With Fluoxetine","status":"COMPLETED","sponsor":"Michigan State University","startDate":"2014-01-01","conditions":"Selective Mutism, Social Anxiety","enrollment":6},{"nctId":"NCT05127369","phase":"NA","title":"Clinical Study on the Safety and Efficacy of Dental Pulp Mesenchymal Cells in the Treatment of Depression","status":"UNKNOWN","sponsor":"CAR-T (Shanghai) Biotechnology Co., Ltd.","startDate":"2022-01-01","conditions":"Depression","enrollment":48},{"nctId":"NCT04640714","phase":"NA","title":"Care Transition Intervention for Patients With Cancer","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2021-01-07","conditions":"Advanced Cancer, Home Care, Hospital-Based","enrollment":58},{"nctId":"NCT02737930","phase":"PHASE2","title":"Fluoxetine for Visual Recovery After Ischemic Stroke","status":"TERMINATED","sponsor":"Bogachan Sahin","startDate":"2016-05","conditions":"Acute Stroke, Visual Field Loss","enrollment":17},{"nctId":"NCT03358771","phase":"NA","title":"COPD Discharge Bundle Delivered Alone or Enhanced Through a Care Coordinator","status":"COMPLETED","sponsor":"University of Alberta","startDate":"2017-03-01","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":3710},{"nctId":"NCT02208466","phase":"PHASE2","title":"Effects rTMS Combined With Fluoxetine on Motor Recovery in Stroke Patients","status":"COMPLETED","sponsor":"Spaulding Rehabilitation Hospital","startDate":"2014-09","conditions":"Stroke, Motor Function","enrollment":44},{"nctId":"NCT00611975","phase":"PHASE4","title":"Effect of Antidepressants on Sex Hormone Levels and Sexual Functioning","status":"COMPLETED","sponsor":"Weill Medical College of Cornell University","startDate":"2005-10","conditions":"Healthy","enrollment":83},{"nctId":"NCT00961961","phase":"PHASE4","title":"Prevention of Relapse & Recurrence of Bipolar Depression","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2009-07-01","conditions":"Bipolar Disorder","enrollment":177},{"nctId":"NCT02431806","phase":"PHASE3","title":"Safety and Efficacy of Levomilnacipran ER in Adolescent Participants With Major Depressive Disorder","status":"COMPLETED","sponsor":"Forest Laboratories","startDate":"2015-06-23","conditions":"Major Depressive Disorder","enrollment":552},{"nctId":"NCT03654963","phase":"NA","title":"Study to Assess the Impact of Medication Reconciliation at Hospital Admission on Healthcare Outcomes","status":"COMPLETED","sponsor":"Ente Ospedaliero Cantonale, Bellinzona","startDate":"2018-11-05","conditions":"Safety Issues","enrollment":1702},{"nctId":"NCT02929667","phase":"PHASE2","title":"Abnormal Ventilatory Response to Carbon Dioxide: a Potential Biomarker for Seizure Induced Respiratory Depression & Modification by SSRI","status":"COMPLETED","sponsor":"Rup Kamal Sainju","startDate":"2017-02-16","conditions":"Epilepsy, SUDEP","enrollment":30},{"nctId":"NCT03893266","phase":"","title":"Diabetic Patients Needs in Therapeutic Education About Work. TE-DIW (Therapeutic Education of DIabetic Working People)","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2019-04-26","conditions":"Diabetes Mellitus, Type 1","enrollment":15},{"nctId":"NCT02017535","phase":"PHASE1, PHASE2","title":"An Adaptive Treatment Strategy for Adolescent Depression-Continuation","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2012-06","conditions":"Adolescent Depression","enrollment":15},{"nctId":"NCT02723903","phase":"PHASE1, PHASE2","title":"Hierarchical Treatment Based on Somatization Symptom Checklist","status":"UNKNOWN","sponsor":"RenJi Hospital","startDate":"2015-12","conditions":"Syndrome X","enrollment":200},{"nctId":"NCT04272476","phase":"PHASE2","title":"The Activation on Prefrontal Cortex With Acupuncture and Moxibustion for Major Depressive Disorder: A Study of Functional Near Infrared Spectroscopy","status":"COMPLETED","sponsor":"Chengdu University of Traditional Chinese Medicine","startDate":"2014-01","conditions":"Depressive Disorder, Major","enrollment":20},{"nctId":"NCT00986310","phase":"NA","title":"Efficacy of Fluoxetine in Reducing Ictal Hypoventilation in Patients With Partial Epilepsy","status":"COMPLETED","sponsor":"University of California, Davis","startDate":"2009-08","conditions":"Uncontrolled Partial Epilepsy, Ictal Hypoventilation","enrollment":2},{"nctId":"NCT00733525","phase":"NA","title":"Effectiveness of Stepped Care Versus Best Available Care for Bulimia Nervosa","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2000-09","conditions":"Eating Disorders","enrollment":293},{"nctId":"NCT01687478","phase":"PHASE3","title":"A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression","status":"TERMINATED","sponsor":"Eli Lilly and Company","startDate":"2012-09","conditions":"Treatment Resistant Depression","enrollment":176},{"nctId":"NCT02372799","phase":"PHASE3","title":"Safety and Efficacy of Vilazodone in Pediatric Patients With Major Depressive Disorder (VLZ-MD-22)","status":"COMPLETED","sponsor":"Forest Laboratories","startDate":"2015-02-28","conditions":"Major Depressive Disorder","enrollment":473},{"nctId":"NCT01802437","phase":"PHASE1, PHASE2","title":"An Adaptive Treatment Strategy for Adolescent Depression","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2010-11","conditions":"Adolescent Depression","enrollment":40},{"nctId":"NCT02389712","phase":"PHASE4","title":"16-week Comparative Effectiveness Trial of Lamotrigine vs. Fluoxetine for Bipolar Depression","status":"TERMINATED","sponsor":"Mayo Clinic","startDate":"2015-03","conditions":"Bipolar Disorder","enrollment":2},{"nctId":"NCT00296725","phase":"PHASE1, PHASE2","title":"Dichotic Listening as a Predictor of Medication Response in Depression","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"1994-04","conditions":"Major Depression, Dysthymia, Depressive Disorder Not Otherwise Specified","enrollment":25},{"nctId":"NCT00787501","phase":"PHASE1","title":"Imaging Antidepressant vs. Cognitive Behavior Therapy Effects on Unipolar Depression","status":"COMPLETED","sponsor":"University of Pittsburgh","startDate":"2008-06","conditions":"Major Depressive Disorder","enrollment":98},{"nctId":"NCT00578669","phase":"PHASE3","title":"Sequential Use of Fluoxetine for Smokers With Elevated Depressive Symptoms","status":"COMPLETED","sponsor":"Butler Hospital","startDate":"2008-04","conditions":"Major Depressive Disorder, Nicotine Dependence, Depression","enrollment":206},{"nctId":"NCT01615055","phase":"EARLY_PHASE1","title":"Fluoxetine Prevention Trial","status":"WITHDRAWN","sponsor":"University of California, Los Angeles","startDate":"2018-06","conditions":"Cognitive Dysfunction","enrollment":""},{"nctId":"NCT01360866","phase":"PHASE3","title":"Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder (the Orion Trial)","status":"COMPLETED","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","startDate":"2011-10","conditions":"Depressive Disorder, Depression, Depressive Disorder, Major","enrollment":2944},{"nctId":"NCT00909155","phase":"NA","title":"Brain Imaging Techniques That Predict Antidepressant Responsiveness","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2002-07","conditions":"Major Depressive Disorder","enrollment":50},{"nctId":"NCT00678574","phase":"PHASE4","title":"The Role of GABA and Neurosteroids in Premenstrual Dysphoric Disorder","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"1998-03","conditions":"Premenstrual Dysphoric Disorder, Premenstrual Syndrome","enrollment":45},{"nctId":"NCT02238977","phase":"PHASE4","title":"Bupropion for Depression in ESRD Patients on Hemodialysis","status":"TERMINATED","sponsor":"University of Arkansas","startDate":"2016-03-31","conditions":"Major Depression, End Stage Renal Disease","enrollment":1},{"nctId":"NCT01361217","phase":"NA","title":"The Effects of Multiple Dose Fluoxetine and Metabolites on CYP1A2, CYP2C19, CYP2D6 and CYP3A4 Activity","status":"COMPLETED","sponsor":"University of Washington","startDate":"2011-09","conditions":"Drug-Drug Interaction, Healthy Volunteers","enrollment":10},{"nctId":"NCT00245635","phase":"PHASE4","title":"Fluoxetine in Pediatric Body Dysmorphic Disorder","status":"COMPLETED","sponsor":"Montefiore Medical Center","startDate":"2004-11","conditions":"Body Dysmorphic Disorder","enrollment":43},{"nctId":"NCT01714310","phase":"PHASE2","title":"Characterization and Sequential Pharmacotherapy of Severe Mood Dysregulation","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2013-01","conditions":"Severe Mood Dysregulation","enrollment":34},{"nctId":"NCT03436173","phase":"NA","title":"OxSYPan: Oxford Study With Young People on Antidepressants","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2012-05-23","conditions":"Depression","enrollment":32},{"nctId":"NCT01740726","phase":"NA","title":"Comparison of Behavioral Activation and Antidepressant Medication in the Treatment of Adolescents With Depression","status":"TERMINATED","sponsor":"Emory University","startDate":"2013-01","conditions":"Major Depressive Disorder","enrollment":3},{"nctId":"NCT01916824","phase":"PHASE4","title":"Effects of Treatment on Decision-making in Major Depression","status":"COMPLETED","sponsor":"Emory University","startDate":"2013-08","conditions":"Major Depressive Disorder, Healthy Controls","enrollment":53},{"nctId":"NCT00466609","phase":"PHASE4","title":"Using Drug Augmentation to Treat Obsessive Compulsive Disorder Patients Who Did Not Respond to Previous Treatment","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2007-05","conditions":"Obsessive Compulsive Disorder","enrollment":54},{"nctId":"NCT01824433","phase":"PHASE4","title":"Comparison of Venlafaxine and Fluoxetine in the Treatment of Postmenopausal Women With Major Depression","status":"COMPLETED","sponsor":"Capital Medical University","startDate":"2013-03-07","conditions":"Major Depression","enrollment":189},{"nctId":"NCT00849901","phase":"PHASE3","title":"A Study in the Treatment of Children and Adolescents With Major Depressive Disorder","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2009-03","conditions":"Major Depressive Disorder","enrollment":337},{"nctId":"NCT03051451","phase":"PHASE2","title":"Fixed Dose Combination of Fluoxetin and Metformin in the Management of Overweight and Obesity","status":"SUSPENDED","sponsor":"Laboratorios Silanes S.A. de C.V.","startDate":"","conditions":"Overweight and Obesity","enrollment":150},{"nctId":"NCT00834834","phase":"PHASE4","title":"Comparing Treatments for Self-Injury and Suicidal Behavior in People With Borderline Personality Disorder","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2009-03","conditions":"Borderline Personality Disorder, Suicide","enrollment":84},{"nctId":"NCT00011765","phase":"PHASE2","title":"Effect of Fluoxetine (Prozac) on Domestic Violence","status":"COMPLETED","sponsor":"National Institute on Alcohol Abuse and Alcoholism (NIAAA)","startDate":"2001-02-22","conditions":"Domestic Violence","enrollment":104},{"nctId":"NCT00676026","phase":"NA","title":"Impact of GABA-Enhancing Agents on Cortical GABA Concentrations Across the Menstrual Cycle in Women","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2005-05","conditions":"Healthy","enrollment":8},{"nctId":"NCT00339079","phase":"PHASE1, PHASE2","title":"Treatment of Hypochondriasis With CBT and/or SSRI","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2006-06","conditions":"Hypochondriasis","enrollment":195},{"nctId":"NCT01944657","phase":"NA","title":"Supplemental Transcranial Magnetic Stimulation (TMS) vs. Standard Medication Monotherapy for Treating Major Depression: An Exploratory Field Study","status":"WITHDRAWN","sponsor":"Sheppard Pratt Health System","startDate":"2013-09","conditions":"1. Major Depressive Disorder","enrollment":""},{"nctId":"NCT00913588","phase":"PHASE1","title":"To Demonstrate the Relative Bioavailability of Geneva and Dista (Prozac) 20 mg Fluoxetine Hydrochloride Capsules (Pulvules) In Healthy Adult Males Under Fed and Fasted Conditions","status":"COMPLETED","sponsor":"Sandoz","startDate":"1996-05","conditions":"Depression","enrollment":24},{"nctId":"NCT00913718","phase":"PHASE1","title":"To Demonstrate the Relative Bioavailability of Geneva and Dista (Prozac) 20 mg Fluoxetine Hydrochloride Capsules (Pulvules) In Healthy Adult Males Under Fasting Conditions","status":"COMPLETED","sponsor":"Sandoz","startDate":"1996-06","conditions":"Depression","enrollment":46},{"nctId":"NCT00947076","phase":"PHASE1","title":"To Demonstrate the Relative Bioavailability of Fluoxetine Hydrochloride Capsules, 40 mg","status":"COMPLETED","sponsor":"Sandoz","startDate":"2001-02","conditions":"Depression","enrollment":30},{"nctId":"NCT00115804","phase":"PHASE3","title":"Safety and Efficacy of Fluoxetine in Juvenile Fibromyalgia","status":"COMPLETED","sponsor":"University of Cincinnati","startDate":"2005-06","conditions":"Juvenile Primary Fibromyalgia Syndrome (JPFS), Fibromyalgia","enrollment":6},{"nctId":"NCT00061113","phase":"PHASE4","title":"Substance Dependent Teens - Impact of Treating Depression Study 1 - 1","status":"COMPLETED","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2001-02","conditions":"Alcohol-Related Disorders, Marijuana Abuse, Substance-Related Disorders","enrollment":126},{"nctId":"NCT02916238","phase":"PHASE4","title":"Measurement-based Care for Depression in Resource-Poor Settings","status":"COMPLETED","sponsor":"Florida International University","startDate":"2014-02","conditions":"Major Depression","enrollment":140},{"nctId":"NCT02965274","phase":"PHASE1","title":"Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Fluoxetine Tablets Under Fed Conditions","status":"COMPLETED","sponsor":"Torrent Pharmaceuticals Limited","startDate":"2013-11","conditions":"Healthy Subjects","enrollment":26},{"nctId":"NCT02965261","phase":"PHASE1","title":"Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Fluoxetine Tablet Under Fasting Conditions","status":"COMPLETED","sponsor":"Torrent Pharmaceuticals Limited","startDate":"2013-11","conditions":"Healthy Subjects","enrollment":26},{"nctId":"NCT02476136","phase":"","title":"Initial Severity and Antidepressant Efficacy for Anxiety Disorders: an Individual Patient Data Meta-analysis","status":"UNKNOWN","sponsor":"prof. Peter de Jonge","startDate":"2015-05","conditions":"Anxiety Disorders, Panic Disorder, Obsessive-compulsive Disorder","enrollment":8800},{"nctId":"NCT00603018","phase":"NA","title":"PET Imaging Study of Recovered Anorexics","status":"COMPLETED","sponsor":"University of Pittsburgh","startDate":"2007-06","conditions":"Anorexia Nervosa","enrollment":23},{"nctId":"NCT00531518","phase":"NA","title":"Early Detection and Intervention for the Prevention of Psychosis","status":"COMPLETED","sponsor":"MaineHealth","startDate":"2007-10","conditions":"Schizophrenia, Bipolar Disorder, Depression","enrollment":292},{"nctId":"NCT01296633","phase":"NA","title":"Medtable: An Electronic Medical Record (EMR) Strategy to Promote Patient Medication Understanding and Use","status":"COMPLETED","sponsor":"University of Illinois at Urbana-Champaign","startDate":"2011-02","conditions":"Diabetes Mellitus","enrollment":674},{"nctId":"NCT00797966","phase":"PHASE2","title":"Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder","status":"COMPLETED","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","startDate":"2009-05","conditions":"Major Depressive Disorder","enrollment":850}],"_emaApprovals":[],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"crossReferences":{"chemblId":"CHEMBL41"},"formularyStatus":[],"_approvalHistory":[{"date":"19920121","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"20110404","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"20141010","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"19940706","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"19921223","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"19950912","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"20110404","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"20130726","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"19900607","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"19930325","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"19910409","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"20090319","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"20110404","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"19900607","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"19920820","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"20040819","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"20080309","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"19900607","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"20090319","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"19881026","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"19890208","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"20020612","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"20070802","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"19900607","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"19990616","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"19880928","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"20051201","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"19890217","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"20020729","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"19961121","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"19990211","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"20051201","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"19980403","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"20001128","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"20200428","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"19880506","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"20020729","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"20160801","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"19950301","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"19980529","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"20130103","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"20140718","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"19950301","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"19980313","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"20211006","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"19961230","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"20110615","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"20170324","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"20090130","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"19920121","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"20130726","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"19900607","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"19950109","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"20080626","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"19920121","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"20070315","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"19900607","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"19930818","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"20080321","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"19910409","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"20060920","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"19881117","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"19900607","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"20070802","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"19900607","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"19880622","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"20060411","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"19890216","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"20000706","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"20050218","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"19871229","type":"ORIG","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"19881117","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"20030103","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"19880928","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"19981020","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"20040903","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"20001128","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"20170104","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"19990615","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"19970917","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"20001128","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"20151124","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"19950912","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"19991007","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"20230818","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"20130103","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"19970325","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"19980706","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"},{"date":"20090622","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"NDA018936"}],"developmentCodes":[],"ownershipHistory":[],"publicationCount":501,"therapeuticAreas":["Neuroscience"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Prozac","genericName":"Prozac","companyName":"RenJi Hospital","companyId":"renji-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T02:39:24.653845+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"verified","dataCompleteness":{"mechanism":false,"indications":true,"safety":true,"trials":true,"score":3}}